Case Study: Top 5 Global Pharma Company achieves trial continuity in Ukraine and a scalable global risk‑mitigation platform with Florence Healthcare

How Florence Enabled a Top 5 Pharma to Keep Studies Operational in Ukraine and Build a Global Platform to Mitigate Future Risks

Top 5 Global Pharma Company faced urgent disruptions to clinical trials during the 2022 conflict in Ukraine — with over 1,000 patients enrolled, risks to patient safety, data integrity, and regulatory compliance threatened trial continuity. The company partnered with Florence Healthcare to deploy its Site Experience Platform, including the eISF and SiteLink®, to enable secure remote access to site documents and maintain operations.

Florence Healthcare centralized documentation and enabled real-time remote monitoring (SDR/SDV), certified audit trails, and secure sharing to preserve compliance and investigator engagement. Within two months the company resumed monitoring across 170 global sites, retained over 90% of Ukrainian participants, regained inspection readiness within six months, and scaled Florence’s platform to 4,500+ sites by January 2025 — substantially reducing delays and strengthening global trial resilience.